Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Supraclavicular recurrence after early breast cancer: a curable condition?
Pedersen AN, Møller S, Steffensen KD, Haahr V, Jensen M, Kempel MM, Jepsen SL, Madsen EL, Roslind A, Sandberg E, Schöllkopf C, Sørensen PG, Windfeldt KM, Andersson M. Pedersen AN, et al. Among authors: roslind a. Breast Cancer Res Treat. 2011 Feb;125(3):815-22. doi: 10.1007/s10549-010-0918-8. Epub 2010 May 8. Breast Cancer Res Treat. 2011. PMID: 20454924
Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.
Lænkholm AV, Jensen MB, Eriksen JO, Roslind A, Buckingham W, Ferree S, Nielsen T, Ejlertsen B. Lænkholm AV, et al. Among authors: roslind a. Clin Breast Cancer. 2020 Aug;20(4):e423-e432. doi: 10.1016/j.clbc.2020.01.013. Epub 2020 Feb 4. Clin Breast Cancer. 2020. PMID: 32253134
PD-L1 diagnostics in the neoadjuvant setting: implications of intratumoral heterogeneity of PD-L1 expression in triple negative breast cancer for assessment in small biopsies.
Stovgaard ES, Bokharaey M, List-Jensen K, Roslind A, Kümler I, Høgdall E, Nielsen D, Balslev E. Stovgaard ES, et al. Among authors: roslind a. Breast Cancer Res Treat. 2020 Jun;181(3):553-560. doi: 10.1007/s10549-020-05655-w. Epub 2020 May 2. Breast Cancer Res Treat. 2020. PMID: 32358635
Serum YKL-40, a new prognostic biomarker in cancer patients?
Johansen JS, Jensen BV, Roslind A, Nielsen D, Price PA. Johansen JS, et al. Among authors: roslind a. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):194-202. doi: 10.1158/1055-9965.EPI-05-0011. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16492905 Review.
Prognostic utility of serum YKL-40 in patients with cervical cancer.
Roslind A, Palle C, Johansen JS, Christensen IJ, Nielsen HJ, Mosgaard BJ. Roslind A, et al. Scand J Clin Lab Invest. 2020 Dec;80(8):687-693. doi: 10.1080/00365513.2020.1846209. Epub 2020 Nov 13. Scand J Clin Lab Invest. 2020. PMID: 33186077
24 results